Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria F Botero"'
Autor:
Stacy L Schmidt, Matthew S Hickey, Kathryn M Koblenz, Holly Klamer, Maria F Botero, Kyle T Pfaffenbach, Michael J Pagliassotti, Christopher L Melby
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16987 (2011)
BACKGROUND: Young adult Mexican Americans (MA) exhibit lower insulin sensitivity (Si) than nonHispanic whites (NHW), even when controlling for fitness and adiposity. It is unclear if MA are as responsive to the same lifestyle intervention as NHW. OBJ
Externí odkaz:
https://doaj.org/article/e16e20d7fdd84f4aa6f17cb9720c5e80
Autor:
Guang Hu, Natalya N. Pavlova, C. Kent Osborne, Don X. Nguyen, Chunshui Zhou, Ronald J. Bernardi, Chad J. Creighton, Stephen J. Elledge, Thomas F. Westbrook, Maria F. Botero, Chad A. Shaw, David A. Wheeler, Steven P. Gygi, Earlene M. Schmitt, Jian Huang, Jessica D. Kessler, Mohamed Bentires-Alj, Richard A. Gibbs, Rachel Schiff, Mitchell Rao, Kristen L. Meerbrey, Tingting Sun, Mamie Z. Li, Noah Dephoure, Donna M. Muzny, Nicola Aceto, Susan G. Hilsenbeck, I. Migliaccio
Publikováno v:
Cell. 144:703-718
SummaryAmong breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and is refractory to current targeted therapies. Using a genetic screen, we identify the PTPN12 tyrosine phosphatase as a tumor suppressor in TNBC. PTPN12
Autor:
Tf. Westbrook, I. Migliaccio, CK Osborne, Maria F. Botero, Richard A. Gibbs, Earlene M. Schmitt, Stephen J. Elledge, SG Hilsenbeck, Ronald J. Bernardi, Jessica D. Kessler, Tingting Sun, Ca Shaw, D Wheeler, Don X. Nguyen, Rachel Schiff, Natalya N. Pavlova, Chad J. Creighton, Kristen L. Meerbrey
Publikováno v:
Cancer Research. 70:S6-10
Breast cancer is a collection of diseases with distinct clinical behaviors and underlying genetic causes. Triple-negative breast cancer (TNBC) is a common subtype of breast cancer that confers a particularly poor prognosis and is refractory to curren
Autor:
Robin McAninch, Robia G. Pautler, Naomi J. Halas, Carlos J. Perez-Torres, Wenxue Chen, Amit Joshi, Rizia Bardhan, Rachel Schiff, Alejandro Contreras, Maria F. Botero, Marc Bartels
Publikováno v:
Nano Letters. 10:4920-4928
Nanoparticle-based therapeutics with local delivery and external electromagnetic field modulation holds extraordinary promise for soft-tissue cancers such as breast cancer; however, knowledge of the distribution and fate of nanoparticles in vivo is c
Autor:
Gladys Morrison, Rachel Schiff, Yen-Chao Wang, C. Kent Osborne, Ryan M. Gillihan, Xiaoyong Fu, Maria F. Botero, N.A. Healy, Jun Guo, Robin Ward, Mothaffar F. Rimawi, Gail Lewis Phillips, Susan G. Hilsenbeck, Gary C. Chamness
Publikováno v:
Breast Cancer Research : BCR
Introduction: The human epidermal growth factor receptor 2 (HER2)-targeted therapies trastuzumab (T) and lapatinib (L) show high efficacy in patients with HER2-positive breast cancer, but resistance is prevalent. Here we investigate resistance mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61851283188505931fc13368b1363559
http://hdl.handle.net/10379/14378
http://hdl.handle.net/10379/14378
Autor:
Holly Klamer, Michael J. Pagliassotti, Christopher L. Melby, Matthew S. Hickey, Kyle T. Pfaffenbach, Kathryn M. Koblenz, Stacy L. Schmidt, Maria F. Botero
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16987 (2011)
PLoS ONE
PLoS ONE
Background Young adult Mexican Americans (MA) exhibit lower insulin sensitivity (Si) than nonHispanic whites (NHW), even when controlling for fitness and adiposity. It is unclear if MA are as responsive to the same lifestyle intervention as NHW. Obje
Autor:
Matthew S. Hickey, Kathryn M McCabe, Maria F. Botero, Chris Melby, Stacy L. Schmidt, Holly Klamer, Kyle T. Pfaffenbach
Publikováno v:
The FASEB Journal. 23
Autor:
Y-C Wang, M Shea, CK Osborne, Robin Ward, SG Hilsenbeck, Maria F. Botero, X Fu, Rachel Schiff, Chenfei Huang
Publikováno v:
Cancer Research. 70:P4-02
Bidirectional crosstalk between the estrogen receptor (ER) and HER2 has been demonstrated in preclinical model systems. We have previously shown in HER2+ breast cancer cells with low ER that potent HER2- targeted therapy results in ER reactivation th
Autor:
Rizia Bardhan, Wenxue Chen, Marc Bartels, Carlos Perez-Torres, Maria F. Botero, Robin Ward McAninch, Alejandro Contreras, Rachel Schiff, Robia G. Pautler, Naomi J. Halas, Amit Joshi
Publikováno v:
Nano Letters; Dec2010, Vol. 10 Issue 12, p4920-4928, 9p